A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma

Ricardo Leão, Madhur Nayan, Nahid Punjani, Michael A.S. Jewett, Kamel Fadaak, Juan Garisto, Jeremy Lewin, Eshetu G. Atenafu, Joan Sweet, Lynn Anson-Cartwright, Peter Boström, Peter Chung, Padraig Warde, Philippe L. Bedard, Aditya Bagrodia, Yuval Freifeld, Nicholas Power, Eric Winquist, Robert J. Hamilton

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The Princess Margaret model (PMM) has higher accuracy and sensitivity in the prediction of residual benign histology when compared with other models. The PMM identifies a higher number of patients for whom retroperitoneal lymph node dissection can be avoided, and gives confidence to be used as an extensive and prospective clinical application.

Original languageEnglish (US)
Pages (from-to)995-1001
Number of pages7
JournalEuropean Urology Focus
Volume4
Issue number6
DOIs
StatePublished - Dec 2018

Keywords

  • Nonseminoma germ cell testicular cancer
  • Postchemotherapy
  • Predictive model
  • Retroperitoneal lymph node dissection
  • Viable disease

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma'. Together they form a unique fingerprint.

  • Cite this

    Leão, R., Nayan, M., Punjani, N., Jewett, M. A. S., Fadaak, K., Garisto, J., Lewin, J., Atenafu, E. G., Sweet, J., Anson-Cartwright, L., Boström, P., Chung, P., Warde, P., Bedard, P. L., Bagrodia, A., Freifeld, Y., Power, N., Winquist, E., & Hamilton, R. J. (2018). A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma. European Urology Focus, 4(6), 995-1001. https://doi.org/10.1016/j.euf.2018.01.015